Core Insights - Wall Street analysts expect Sherwin-Williams (SHW) to report quarterly earnings of $3.76 per share, reflecting a year-over-year increase of 1.6% [1] - Revenues are projected to be $6.29 billion, which is a slight increase of 0.2% from the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a reevaluation of initial estimates by analysts [1] Revenue Estimates - Analysts predict 'Net sales- Paint Stores Group' to be $3.68 billion, representing a year-over-year increase of 1.6% [4] - 'Net sales- Consumer Brands Group' is expected to reach $826.14 million, indicating a decline of 2.2% year over year [4] - 'Net sales- Performance Coatings Group' is estimated at $1.77 billion, suggesting a decrease of 1.7% from the previous year [4] Store Metrics - The 'Net New Stores - Paint Stores Group' is projected to reach 20, up from 19 in the same quarter last year [5] - The expected 'Number of Stores - Paint Stores Group' is 4,811, compared to 4,720 a year ago [5] Profit Estimates - 'Segment Profit- Paint Stores Group' is anticipated to be $946.70 million, an increase from $907.10 million in the same quarter last year [6] - 'Adjusted segment profit- Performance Coatings Group (PCG)' is expected to be $337.39 million, down from $350.50 million year over year [6] - 'Adjusted segment profit- Consumer Brands Group (CBG)' is projected at $213.90 million, compared to $220.40 million in the previous year [7] Stock Performance - Over the past month, Sherwin-Williams shares have returned +2.5%, while the Zacks S&P 500 composite has changed by +4.2% [7] - Based on its Zacks Rank 2 (Buy), SHW is expected to outperform the overall market in the upcoming period [7]

Overview - Investopedia 分析了过去五任总统（乔·拜登、唐纳德·特朗普、巴拉克·奥巴马、乔治·W·布什和比尔·克林顿）任期内表现最佳的股票 [1] Resource - 完整的文章链接为：https://t.co/yci8MECLco https://t.co/OuI1xKalBi [1]

Core Insights - FB Financial (FBK) reported a revenue of $137.41 million for the quarter ended June 2025, marking a year-over-year increase of 7.2% and exceeding the Zacks Consensus Estimate of $135.28 million by 1.58% [1] - The company's EPS for the same period was $0.88, slightly below the consensus estimate of $0.89, reflecting an EPS surprise of -1.12% compared to $0.84 a year ago [1] Financial Performance Metrics - Efficiency Ratio stood at 56.9%, better than the three-analyst average estimate of 57.3% [4] - Net Interest Margin was reported at 3.7%, surpassing the average estimate of 3.6% based on three analysts [4] - Average Earning Assets totaled $12.24 billion, below the two-analyst average estimate of $12.57 billion [4] - Net Charge-offs during the period to Average Loans outstanding were 0%, compared to the average estimate of 0.1% [4] - Mortgage banking income reached $13.03 million, exceeding the three-analyst average estimate of $12.8 million [4] - Total Noninterest income was $26 million, higher than the average estimate of $24.69 million [4] - Net interest income (tax-equivalent basis) was $112.24 million, slightly above the average estimate of $111.95 million [4] - Other Income amounted to $2.54 million, compared to the average estimate of $2.25 million [4] - Service charges on deposit accounts were $3.39 million, slightly below the average estimate of $3.46 million [4] - Net Interest Income was reported at $111.42 million, marginally below the two-analyst average estimate of $111.61 million [4] - ATM and interchange fees totaled $2.88 million, exceeding the two-analyst average estimate of $2.83 million [4] - Investment services and trust income reached $3.92 million, surpassing the two-analyst average estimate of $3.63 million [4] Stock Performance - FB Financial shares have returned +11.6% over the past month, outperforming the Zacks S&P 500 composite's +4% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Core Viewpoint - Analysts forecast that Elevance Health (ELV) will report quarterly earnings of $9.20 per share, indicating a year-over-year decline of 9.1%, while revenues are expected to reach $48.13 billion, reflecting an increase of 11.4% compared to the previous year [1] Revenue Estimates - The consensus estimate for 'Revenues- Premiums' is $39.62 billion, suggesting a year-over-year increase of 11.9% [5] - 'Revenues- Service fees' are expected to be $2.24 billion, indicating a decline of 1.8% year over year [5] - 'Revenues- Net investment income' is projected at $464.67 million, reflecting a decrease of 8.5% from the year-ago quarter [5] - 'Revenues- Product revenue' is forecasted to reach $6.14 billion, showing an increase of 11.1% from the previous year [6] Membership Estimates - 'Medical Membership - Medicare - Medicare Supplement' is expected to be 868.88 thousand, down from 894.00 thousand year over year [6] - 'Medical Membership - Commercial Risk-Based - Employer Group Risk-Based' is projected at 3.64 million, slightly down from 3.65 million in the same quarter last year [7] - 'Medical Membership - Commercial Risk-Based' is estimated at 5.00 million, up from 4.93 million year over year [7] - Total Medical Membership is expected to be 45.83 million, a slight increase from 45.78 million year over year [8] - 'Medical Membership - Medicare - Medicare Advantage' is projected to reach 2.24 million, up from 2.03 million year over year [8] - 'Medical Membership - Medicaid' is expected to be 8.86 million, down from 9.03 million year over year [9] - 'Medical Membership - Federal Employees Health Benefits' is projected at 1.65 million, slightly down from 1.66 million year over year [9] Stock Performance - Over the past month, shares of Elevance Health have returned -11.4%, contrasting with the Zacks S&P 500 composite's +4% change [9]

Core Viewpoint - Nvidia shares have increased by approximately 11.4% since the last earnings report, outperforming the S&P 500, raising questions about the sustainability of this positive trend leading up to the next earnings release [1] Group 1: Earnings Report and Estimates - Fresh estimates for Nvidia have trended upward over the past month, indicating positive sentiment among analysts [2] - The most recent earnings report serves as a catalyst for understanding the stock's performance and future outlook [1] Group 2: VGM Scores - Nvidia has a strong Growth Score of A, but is lagging in Momentum Score with an F, and has a Value Score of D, placing it in the bottom 40% for that investment strategy [3] - The aggregate VGM Score for Nvidia is C, which is relevant for investors not focused on a single strategy [3] Group 3: Outlook - The upward trend in estimates suggests a promising outlook for Nvidia, with a Zacks Rank of 3 (Hold), indicating expectations for an in-line return in the coming months [4]

Core Insights - McCormick reported revenue of $1.66 billion for the quarter ended May 2025, reflecting a 1% increase year-over-year, with EPS remaining stable at $0.69 compared to the same quarter last year [1] - The revenue fell short of the Zacks Consensus Estimate by -0.22%, while the EPS exceeded the consensus estimate by +6.15% [1] Financial Performance - Net Sales in Flavor Solutions were reported at $729 million, which is -1.3% lower than the estimated $746.82 million [4] - Net Sales in the Consumer segment reached $931 million, surpassing the estimated $918.28 million, marking a year-over-year increase of +2.9% [4] - Operating income for Flavor Solutions, excluding special charges, was $95 million, exceeding the average estimate of $92.07 million [4] - Operating income for the Consumer segment was reported at $164 million, also above the average estimate of $152.43 million [4] Stock Performance - McCormick's shares have returned +3.2% over the past month, underperforming the Zacks S&P 500 composite's +5.1% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Viewpoint - Accenture (ACN) is expected to report quarterly earnings of $3.29 per share, a 5.1% increase year-over-year, with revenues projected at $17.21 billion, reflecting a 4.5% year-over-year growth [1]. Earnings Estimates - The consensus EPS estimate has been revised 1.3% higher in the last 30 days, indicating a collective reevaluation by analysts [2]. - Revisions to earnings estimates are significant indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue Estimates - Analysts forecast 'Revenue- Type of Work- Consulting' at $8.63 billion, a 2.1% increase from the prior year [5]. - 'Revenue- Type of Work- Managed Services' is expected to reach $8.56 billion, reflecting a 6.9% increase year-over-year [5]. - 'Revenue- Industry Groups- Product' is projected at $5.19 billion, indicating a 4.2% year-over-year change [5]. - 'Revenue- Industry Groups- Health & Public Service' is likely to reach $3.76 billion, a 6.9% increase year-over-year [6]. - 'Revenue- Industry Groups- Financial Services' is estimated at $2.94 billion, reflecting a 1.5% year-over-year change [6]. - 'Revenue- Industry Groups- Communications, Media & Technology' is forecasted at $2.82 billion, indicating a 2% year-over-year change [6]. - 'Geographic Revenue- Americas' is estimated at $8.75 billion, a significant 11.7% increase from the prior year [7]. - 'Geographic Revenue- Asia Pacific' is expected to decline to $2.22 billion, a 22.3% decrease year-over-year [7]. - 'Geographic Revenue- EMEA' is projected at $6.12 billion, reflecting a 6% year-over-year increase [7]. New Bookings Estimates - The average prediction for 'New Bookings - Total' is $21.44 billion, compared to $21.06 billion in the same quarter last year [8]. - 'New Bookings - Managed Services' is expected to reach $11.92 billion, up from $11.78 billion year-over-year [8]. - 'New Bookings - Consulting' is projected at $9.52 billion, an increase from $9.28 billion in the previous year [9]. Stock Performance - Over the past month, Accenture shares have recorded a return of -1.9%, while the Zacks S&P 500 composite has seen a +1.7% change [9]. - Based on its Zacks Rank 3 (Hold), Accenture is expected to perform in line with the overall market in the upcoming period [10].

Core Viewpoint - GMS is expected to report a significant decline in quarterly earnings and revenues, indicating potential challenges in its business performance [1]. Financial Performance - Analysts predict GMS will post quarterly earnings of $1.15 per share, a decline of 40.4% year-over-year [1]. - Revenues are forecasted to be $1.3 billion, reflecting a year-over-year decrease of 8.2% [1]. Earnings Estimate Revisions - There have been no revisions in the consensus EPS estimate for the quarter over the past 30 days, indicating stability in analysts' projections [2]. - Revisions to earnings projections are crucial for predicting investor behavior and stock price performance [3]. Key Metrics Analysis - Organic net sales for Wallboard are estimated to decline by 15.3%, contrasting with a 6% increase from the previous year [5]. - Organic net sales for Ceilings are expected to decrease by 0.9%, compared to an 11.4% increase last year [5]. - Organic net sales for Other products/Complementary products are projected to decline by 4.1%, down from a 3.5% increase in the same quarter last year [6]. Market Performance - GMS shares have changed by +2.7% in the past month, compared to a +3.6% move of the Zacks S&P 500 composite [7]. - GMS holds a Zacks Rank 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [7].

Core Viewpoint - J.M. Smucker Company (NYSE:SJM) experienced a significant decline of 12.7% to $97.65 following a disappointing annual profit forecast, despite fiscal fourth-quarter earnings exceeding estimates, while revenue fell short of expectations [1] Group 1: Financial Performance - The company's stock is at its lowest level since March 2020, breaking past its February bottom, indicating a severe market reaction [1] - J.M. Smucker is on track for its worst trading day on record, with a year-over-year deficit of 12.1% [1] Group 2: Options Activity - In the options market, SJM has seen an unusually high volume of trades, with 6,298 calls and 5,517 puts, which is 42 times the typical volume for this time [2] - The most popular options are the June 95 call and the 100 call, with new positions being opened in both [2] Group 3: Analyst Sentiment - Analysts are generally bearish on SJM, with many maintaining neutral ratings following the company's guidance; out of 16 firms, 11 have a "hold" or worse rating [2]

Core Viewpoint - Wall Street analysts anticipate a decline in quarterly earnings and revenues for Dave & Buster's, reflecting a downward trend in performance compared to the previous year [1][4]. Earnings Estimates - Analysts expect Dave & Buster's to report earnings of $1.05 per share, representing a year-over-year decline of 6.3% [1]. - Revenue projections stand at $569.26 million, down 3.2% from the same quarter last year [1]. - The consensus EPS estimate has been revised upward by 2.4% over the past 30 days, indicating a reappraisal of initial projections by analysts [1]. Revenue Breakdown - 'Entertainment revenues' are forecasted to reach $374.14 million, reflecting a decrease of 3% from the prior-year quarter [4]. - 'Food and beverage revenues' are expected to total $195.08 million, indicating a decline of 3.6% from the previous year [4]. - The 'Stores Count - End of Period' is projected to be 234, an increase from 224 in the prior year [4]. Stock Performance - Over the past month, Dave & Buster's shares have increased by 12.9%, outperforming the Zacks S&P 500 composite, which saw a 5.2% change [5]. - The company holds a Zacks Rank of 3 (Hold), suggesting that its performance is likely to align with the overall market in the near future [5].